Clinical trials
Completed Phase 1/2 Medulloblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 4 |
| National Cancer Institute (NCI) | 2 |
| Eli Lilly and Company | 1 |
| Lawrence Recht | 1 |
| Novartis Pharmaceuticals | 1 |
| Sue O'Dorisio | 1 |
| University of Regensburg | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medulloblastoma | 11 |
| Astrocytoma | 6 |
| Glioblastoma | 6 |
| Glioma | 6 |
| Neuroblastoma | 6 |
| Central Nervous System Neoplasms | 5 |
| Oligodendroglioma | 5 |
| Brain Neoplasms | 4 |
| Gliosarcoma | 4 |
| Neuroectodermal Tumors, Primitive | 4 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.